FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380369293> ?p ?o ?g. }

• W4380369293 abstract "Despite second-line transplant(SLT) for recurrent hepatocellular carcinoma(rHCC) leads to the longest survival after recurrence(SAR), its real applicability has never been reported. The aim was to compare the SAR of SLT versus repeated hepatectomy and thermoablation(CUR group).Patients were enrolled from the Italian register HE.RC.O.LE.S. between 2008 and 2021. Two groups were created: CUR versus SLT. A propensity score matching (PSM) was run to balance the groups.743 patients were enrolled, CUR = 611 and SLT = 132. Median age at recurrence was 71(IQR 6575) years old and 60(IQR 53-64, p < 0.001) for CUR and SLT respectively. After PSM, median SAR for CUR was 43 months(95%CI = 37 - 93) and not reached for SLT(p < 0.001). SLT patients gained a survival benefit of 9.4 months if compared with CUR. MilanCriteria(MC)-In patients were 82.7% of the CUR group. SLT(HR 0.386, 95%CI = 0.23 - 0.63, p < 0.001) and the MELD score(HR 1.169, 95%CI = 1.07 - 1.27, p < 0.001) were the only predictors of mortality. In case of MC-Out, the only predictor of mortality was the number of nodules at recurrence(HR 1.45, 95%CI= 1.09 - 1.93, p = 0.011).It emerged an important transplant under referral in favour of repeated hepatectomy or thermoablation. In patients with MC-Out relapse, the benefit of SLT over CUR was not observed." @default.
• W4380369293 created "2023-06-13" @default.
• W4380369293 creator A5000689321 @default.
• W4380369293 creator A5001100012 @default.
• W4380369293 creator A5001598786 @default.
• W4380369293 creator A5001654523 @default.
• W4380369293 creator A5004113834 @default.
• W4380369293 creator A5004180117 @default.
• W4380369293 creator A5004194154 @default.
• W4380369293 creator A5004591830 @default.
• W4380369293 creator A5007268728 @default.
• W4380369293 creator A5007361251 @default.
• W4380369293 creator A5007593501 @default.
• W4380369293 creator A5007965103 @default.
• W4380369293 creator A5008388094 @default.
• W4380369293 creator A5008967734 @default.
• W4380369293 creator A5012716489 @default.
• W4380369293 creator A5014178344 @default.
• W4380369293 creator A5017949124 @default.
• W4380369293 creator A5019071090 @default.
• W4380369293 creator A5020323314 @default.
• W4380369293 creator A5021419014 @default.
• W4380369293 creator A5021781945 @default.
• W4380369293 creator A5021898630 @default.
• W4380369293 creator A5023140410 @default.
• W4380369293 creator A5024426392 @default.
• W4380369293 creator A5027147759 @default.
• W4380369293 creator A5029293131 @default.
• W4380369293 creator A5029645660 @default.
• W4380369293 creator A5031089579 @default.
• W4380369293 creator A5031540860 @default.
• W4380369293 creator A5031842041 @default.
• W4380369293 creator A5032115067 @default.
• W4380369293 creator A5032121417 @default.
• W4380369293 creator A5032258617 @default.
• W4380369293 creator A5032970001 @default.
• W4380369293 creator A5033775978 @default.
• W4380369293 creator A5035435527 @default.
• W4380369293 creator A5035464723 @default.
• W4380369293 creator A5036466498 @default.
• W4380369293 creator A5038146297 @default.
• W4380369293 creator A5038166701 @default.
• W4380369293 creator A5038628543 @default.
• W4380369293 creator A5039259452 @default.
• W4380369293 creator A5039559137 @default.
• W4380369293 creator A5042103105 @default.
• W4380369293 creator A5042643092 @default.
• W4380369293 creator A5048578892 @default.
• W4380369293 creator A5050512903 @default.
• W4380369293 creator A5052311759 @default.
• W4380369293 creator A5052887355 @default.
• W4380369293 creator A5053928194 @default.
• W4380369293 creator A5054453325 @default.
• W4380369293 creator A5060665319 @default.
• W4380369293 creator A5062176003 @default.
• W4380369293 creator A5063726565 @default.
• W4380369293 creator A5064455984 @default.
• W4380369293 creator A5064599624 @default.
• W4380369293 creator A5064605526 @default.
• W4380369293 creator A5069549442 @default.
• W4380369293 creator A5069877095 @default.
• W4380369293 creator A5071449817 @default.
• W4380369293 creator A5071502669 @default.
• W4380369293 creator A5071939318 @default.
• W4380369293 creator A5072007360 @default.
• W4380369293 creator A5072724595 @default.
• W4380369293 creator A5073104114 @default.
• W4380369293 creator A5073122706 @default.
• W4380369293 creator A5073553980 @default.
• W4380369293 creator A5073664177 @default.
• W4380369293 creator A5076528238 @default.
• W4380369293 creator A5078589928 @default.
• W4380369293 creator A5080128801 @default.
• W4380369293 creator A5080802426 @default.
• W4380369293 creator A5081483584 @default.
• W4380369293 creator A5084395592 @default.
• W4380369293 creator A5085679623 @default.
• W4380369293 creator A5086269020 @default.
• W4380369293 creator A5086787753 @default.
• W4380369293 creator A5088909032 @default.
• W4380369293 creator A5089100890 @default.
• W4380369293 creator A5089127523 @default.
• W4380369293 creator A5089940988 @default.
• W4380369293 creator A5090502272 @default.
• W4380369293 creator A5091003529 @default.
• W4380369293 creator A5091294136 @default.
• W4380369293 creator A5092148418 @default.
• W4380369293 date "2023-06-01" @default.
• W4380369293 modified "2023-10-04" @default.
• W4380369293 title "Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario" @default.
• W4380369293 cites W1606824532 @default.
• W4380369293 cites W1654905476 @default.
• W4380369293 cites W1980408776 @default.
• W4380369293 cites W1992892900 @default.
• W4380369293 cites W1994106833 @default.
• W4380369293 cites W2000445173 @default.
• W4380369293 cites W2008423320 @default.
• W4380369293 cites W2008655007 @default.
• W4380369293 cites W2015407907 @default.
• W4380369293 cites W2021299297 @default.

• next